Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hCG Priming Before IVF in Low Ovarian Reserve
NCT04643925Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Dec 2020
- Primary completion
- Aug 2021
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of recombinant human chorionic gonadotrophin in female infertility, sponsored by Rigshospitalet. Primary endpoint: Follicular output rate. Started Dec 2020; status: completed.
02
Drugs
recombinant human chorionic gonadotrophin
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT04643925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04643925.